Kate Xiong

First Rice Partners LLC (First Rice Capital) is a venture capital firm founded in 2016 by Kate Xiong. The firm is headquartered in Cambridge, Massachusetts.

Neutrolis, Inc. is a biotechnology company located in North Cambridge, MA. The company develops first-in-class therapies that target neutrophils and their pathogenic products, including nets. Neutrolis proprietary platform, Chromatinase™, is based on the naturally occurring enzymes that break down the extracellular chromatin that form nets. The company's lead product, NTR-441, is a patented, first-in-class, engineered DNASE1L3 analog with potential application in COVID-19, ARDS, lupus, rheumatoid arthritis, systemic sclerosis, and other net-mediated diseases. Neutrolis has received two competitive LabCentral Golden Ticket awards from Pfizer and Bristol-Myers Squibb. The company was founded by Abdul Hakkim and Toby Fox. Toby Fox has been the CEO since incorporation.

Ant Group Co., Ltd. engages in the development of mobile payment and financial technology open platform. Its products are used for micro-loan technology, financial management, and insurance. The company was founded by Lei Peng on October 19, 2000 and is headquartered in Hangzhou, China.